Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Aisner

Showing results (61-70 of 235) with videos related to

Pageof 24
Sort By:
Progress in Clinical and Biological Research|January 1, 1978
Platelet transfusion therapy for patients with leukemiaC A Schiffer, J Aisner, P H Wiernik
Cancer Clinical Trials|January 1, 1979
Streptozotocin: an inactive agent in small cell carcinomaL H Maurer, R B Weiss, J Aisner
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2000
High-time chemotherapy or high time for low doseB A Kamen, E Rubin, J Aisner, et al.
Seminars in Oncology|August 1, 1995
Paclitaxel and carboplatin with and without filgrastim support in patients with metastatic non-small cell lung cancerC P Belani, J Aisner, D Hiponia, et al.
Cancer Clinical Trials|January 1, 1980
High-dose VP 16-213 (NSC 141540) for the treatment of patients with previously treated acute leukemiaD A Van Echo, P H Wiernik, J Aisner
Medical and Pediatric Oncology|January 1, 1985
Training and oncologists' changing attitudes toward their own cancer therapyN Schnaper, S Tangerose, M N Wesley, et al.
Seminars in Oncology|April 1, 1989
The pharmacology of carboplatinD A Van Echo, M J Egorin, J Aisner
Seminars in Hematology|April 1, 1987
High-dose megestrol acetate for the treatment of advanced breast cancer: dose and toxicitiesJ Aisner, N S Tchekmedyian, M Moody, et al.
Seminars in Oncology|October 1, 1996
Paclitaxel and carboplatin in metastatic non-small cell lung cancer: preliminary results of a phase I studyC P Belani, J Aisner, D Hiponia, et al.
Cancer Treatment Reports|April 1, 1979
cis-Dichlorodiammineplatinum (II) in small cell anaplastic bronchogenic carcinoma: a phase II studyP Dombernowsky, S Sörenson, J Aisner, et al.
Pageof 24

Showing results (61-70 of 235) with videos related to

Sort By:
Pageof 24
Progress in Clinical and Biological Research|January 1, 1978
Platelet transfusion therapy for patients with leukemiaC A Schiffer, J Aisner, P H Wiernik
Cancer Clinical Trials|January 1, 1979
Streptozotocin: an inactive agent in small cell carcinomaL H Maurer, R B Weiss, J Aisner
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2000
High-time chemotherapy or high time for low doseB A Kamen, E Rubin, J Aisner, et al.
Seminars in Oncology|August 1, 1995
Paclitaxel and carboplatin with and without filgrastim support in patients with metastatic non-small cell lung cancerC P Belani, J Aisner, D Hiponia, et al.
Cancer Clinical Trials|January 1, 1980
High-dose VP 16-213 (NSC 141540) for the treatment of patients with previously treated acute leukemiaD A Van Echo, P H Wiernik, J Aisner
Medical and Pediatric Oncology|January 1, 1985
Training and oncologists' changing attitudes toward their own cancer therapyN Schnaper, S Tangerose, M N Wesley, et al.
Seminars in Oncology|April 1, 1989
The pharmacology of carboplatinD A Van Echo, M J Egorin, J Aisner
Seminars in Hematology|April 1, 1987
High-dose megestrol acetate for the treatment of advanced breast cancer: dose and toxicitiesJ Aisner, N S Tchekmedyian, M Moody, et al.
Seminars in Oncology|October 1, 1996
Paclitaxel and carboplatin in metastatic non-small cell lung cancer: preliminary results of a phase I studyC P Belani, J Aisner, D Hiponia, et al.
Cancer Treatment Reports|April 1, 1979
cis-Dichlorodiammineplatinum (II) in small cell anaplastic bronchogenic carcinoma: a phase II studyP Dombernowsky, S Sörenson, J Aisner, et al.
Pageof 24